GLP-1 Biology
GLP-1 Agonist Dropout Rates and Adherence Data
Most patients quit GLP-1 drugs within a year, long before they can work.
Miriam Osei-Bonsu
· 10 min read
Most patients quit GLP-1 drugs within a year, long before they can work.
Three distinct pathways drive GLP-1 nausea, and each needs its own fix.
A look at who leads the GLP-1 market and why patients quit.
Mapping where the receptor sits explains what GLP-1 drugs can do.
Rodent data show GLP-1 drugs curb drinking, but only while dosed.